Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 15:11:744130.
doi: 10.3389/fonc.2021.744130. eCollection 2021.

Focal Prostate Stereotactic Body Radiation Therapy With Correlative Pathological and Radiographic-Based Treatment Planning

Elisha Fredman  1 , Bryan Traughber  1   2 , Michael Kharouta  1 , Tarun Podder  1 , Simon Lo  3 , Lee Ponsky  4 , Gregory MacLennan  5 , Raj Paspulati  6 , Bradley Ellis  1 , Mitchell Machtay  1   2 , Rodney Ellis  1   2
Affiliations

Focal Prostate Stereotactic Body Radiation Therapy With Correlative Pathological and Radiographic-Based Treatment Planning

Elisha Fredman et al. Front Oncol. .

Abstract

Introduction: Advances in multiparametric MRI (mpMRI) combining anatomic and functional imaging can accurately identify foci of adenocarcinoma within the prostate, offering the possibility of partial gland therapy. We performed tandem prospective pilot trials to investigate the feasibility of focal prostate SBRT (f-SBRT) based on correlating diagnostic mpMRI and biopsies with confirmatory pathology in treatment planning.

Materials and methods: Patients with pathologic focal Gleason 6-7 disease and a corresponding PIRADS 4-5 lesion on mpMRI underwent targeted and comprehensive biopsies using MRI/ultrasound fusion under electromagnetic sensor navigation. After rigorous analysis for imaging biopsy concordance, five of 18 patients were eligible to proceed to f-SBRT. Chi-squared test was used for differences from expected outcomes, and concordance was estimated with binomial distribution theory and Wilson's method.

Results: Six patients had Gleason 6 and 12 had Gleason 3 + 4 disease (mean PSA: 5.8 ng/ml, range: 2.2-8.4). Absolute concordance was 43.8% (95% CI: 0.20, 0.64). Patterns of discordance included additional sites of ipsilateral disease, bilateral disease, and negative target. Five were upstaged to a new NCCN risk category necessitating treatment escalation. The five patients with concordant pathology completed three-fraction f-SBRT with sparing of the surrounding normal structures (including contralateral neurovascular bundle), with no reported grade 2+ toxicities and favorable PSA responses (mean: 41% decrease).

Conclusions: On our pilot trials of f-SBRT planning using rigorous imaging and pathology concordance, image-guided confirmatory biopsies frequently revealed additional disease, suggesting the need for caution in partial-gland therapy. For truly focal disease, f-SBRT provided excellent dosimetry, minimal toxicity, and encouraging biochemical response. Clinical Trial Registration: www.clinicaltrials.gov, NCT02681614; NCT02163317.

Keywords: MRI; SBRT; focal; prostate; radiation.

PubMed Disclaimer

Conflict of interest statement

BT reports grants from Philips Healthcare and from Elekta during the conduct of the study. MM reports nonfinancial support from Elekta and personal fees and nonfinancial support from Philips during the conduct of the study. RE reports nonfinancial support from Elekta and personal fees and nonfinancial support from Philips during the conduct of the study. In addition, RE has two patents U.S. Patents 7831293 and 10842469 with royalties paid by Philips. SL reports past travel and research support from Elekta when the study was developed and current membership of the Elekta ICON Gamma Knife Expert Group. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Targeted and repeat whole-gland biopsies using the UroNav needle guidance system.
Figure 2
Figure 2
Representative axial CT slice with isodose lines from a delivered f-SBRT plan demonstrating sparing of the uninvolved prostate gland, bladder, rectum, urethra, and contralateral neurovascular bundle.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Turkbey B, Mani H, Shah V, Rastinehad AR, Bernardo M, Pohida T, et al. . Multiparametric 3T Prostate Magnetic Resonance Imaging to Detect Cancer: Histopathological Correlation Using Prostatectomy Specimens Processed in Customized Magnetic Resonance Imaging Based Molds. J Urol (2011) 186(5):1818–24. doi: 10.1016/j.juro.2011.07.013 - DOI - PMC - PubMed
    1. Glazer DI, Hassanzadeh E, Fedorov A, Olubiyi OI, Goldberger SS, Penzkofer T, et al. . Diffusion-Weighted Endorectal MR Imaging at 3T for Prostate Cancer: Correlation With Tumor Cell Density and Percentage Gleason Pattern on Whole Mount Pathology. Abdom Radiol (NY) (2017) 42(3):918–25. doi: 10.1007/s00261-016-0942-1 - DOI - PMC - PubMed
    1. Hegde JV, Mulkern RV, Panych LP, Fennessy FM, Fedorov A, Maier SE, et al. . Multiparametric MRI of Prostate Cancer: An Update on State-of-the-Art Techniques and Their Performance in Detecting and Localizing Prostate Cancer. J Magn Reson Imaging (2013) 37(5):1035–54. doi: 10.1002/jmri.23860 - DOI - PMC - PubMed
    1. El-Samei HAE-KA, Amin MF, Hassan EE. Assessment of the Accuracy of Multi-Parametric MRI With PI-RADS 2.0 Scoring System in the Discrimination of Suspicious Prostatic Focal Lesions. Egyp J Radiol Nuc Med (2016) 47(3):1075–82. doi: 10.1016/j.ejrnm.2016.04.022 - DOI
    1. Abd-Alazeez M, Ahmed HU, Arya M, Charman SC, Anastasiadis E, Freeman A, et al. . The Accuracy of Multiparametric MRI in Men With Negative Biopsy and Elevated PSA Level - Can it Rule Out Clinically Significant Prostate Cancer? Urol Oncol (2014) 32(1):45.e17–22. doi: 10.1016/j.urolonc.2013.06.007 - DOI - PMC - PubMed

Associated data